ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
Laxative: Treatment of opioid-induced constipation (OIC)
Peripheral acting µ-opioid receptor antagonist
(17RS)-17-(cyclopropylmetyl)-4,5α-epoxy-3,14-dihydroxy-17-metyl-6-oxo-14beta-morphinanium bromide (WHO)
Morphinanium, (17S)-17-(cyclopropylmetyl)-4,5α-epoxy-3,14-dihydroxy-17-metyl-6-oxo-, bromide, (5α)-[USAN]
- Methylnaltrexonii bromidum (Latin)
- Methylnaltrexon bromid (German)
- Bromure de méthylnaltrexone (French)
- Bromuro de metilnaltrexona (Spanish)
- Methylnaltrexone Bromide (OS: USAN, BAN)
- MNTX (IS)
- MOA-728 (IS)
- MRZ 2663 BR (IS)
Bausch & Lomb Swiss, Switzerland; Link, Australia; Pfizer, Argentina; Pfizer, Canada; Salix, United States; TMC, Spain; TMC, Greece; TMC, Hungary; TMC Pharma, Belgium; TMC Pharma, France; TMC Pharma, Croatia (Hrvatska); TMC Pharma, Ireland; TMC Pharma, Portugal; TMC Pharma Services, Austria; TMC Pharma Services, Denmark; TMC Pharma Services, United Kingdom; TMC Pharma Services, Lithuania; TMC Pharma Services Ltd, Norway; TMC Pharma Services Ltd., Italy; Wyeth, Netherlands; Wyeth, Serbia; Wyeth Europe, Poland; Wyeth-Lederle, Czech Republic
|BAN||British Approved Name|
|IUPAC||International Union of Pure and Applied Chemistry|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
|WHO||World Health Organization|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.